Dr. Zhaoping Li, MD

Dr. Li practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Li's NPI, 1851310684, was assigned on July 19, 2006. Dr. Li graduated from Beijing Medical University in 1986. Dr. Li's California license number on file is A55523.

Dr. Li's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Li's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Li is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Li to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Li is board certified in board cerfitied physician nutrition specialist by the National Board of Physician Nutrition Specialists. Dr. Li has a license on file in California.

Dmand AI lists arthritis, chronic diabetes, chronic hypertension, gastroenteritis, high cholesterol, joint pain, lower back pain and obesity among the conditions Dr. Li treats.

CMS data shows 72 Medicare services from Dr. Li across 3 procedure codes in 2024, all of them office visits, for 65 Medicare patients. Medicare paid $5,522 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Li in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 58, with 71% women.

In 2024, Dr. Li wrote 160 Medicare Part D claims for 26 patients. 59% of them were for generic drugs. CMS names the drug for 132 of them, across 5 drugs with 11 or more claims each, at $57,859 in total drug cost. In 2023, CMS named 69 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Li for performance year 2024, reported as part of a group. Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Li as offering telehealth.

Dmand AI links 65 papers to Dr. Li, published from 2010 to 2025. 2015 was the busiest year, with 5. The most frequent topics are Diet, Obesity and Amino Acids, Branched-Chain. Dr. Li has published most often in Phys Rev Lett. Dr. Li's most frequent co-authors are Sindhu Addepalli, MD, Antonia F. Chen, MD and Zhen Shao Huang, MD.

Dmand AI links Dr. Li to 20 clinical trials, 2 of them phase 2/3 studies. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Glucose Intolerance and Diabetes Mellitus, Type 2. University of California, Los Angeles sponsors the most, 17.

CMS Open Payments shows 5 general payments to Dr. Li from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $210.

Dmand AI lists 1 award for Dr. Li.

Dr. Li graduated from Beijing Medical University in 1986.

Dr. Li is in network with 6 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.